Back to feed
National Law Review
National Law Review
7/1/2026
OIG Seeks Comment on Clinical Trial Participant Remuneration Under the AKS and Beneficiary Inducements CMP

OIG Seeks Comment on Clinical Trial Participant Remuneration Under the AKS and Beneficiary Inducements CMP

Short summary

The HHS Office of Inspector General is soliciting public comment on regulatory safe harbors for clinical trial participant compensation, addressing participation barriers through cost-sharing, travel, childcare, and stipends. Comments due August 24, 2026, with guidance covering safeguards like IRB review and value caps.

  • •OIG seeking stakeholder input on regulatory safe harbors for trial participant payments to increase enrollment
  • •Comment deadline: August 24, 2026; addresses AKS and Beneficiary Inducements CMP compliance
  • •Covers cost-sharing support, travel, lodging, childcare, stipends with IRB review and anti-steering protections

Generated with AI, which can make mistakes.

#regulation-policy#industry-adoption#ai-tools
Read full article at National Law Review

Is this a good recommendation for you?

Comments

Failed to load comments. Please try again.

Explore more

CMS Seeks Broad Stakeholder Input on CLIA Regulations, Signaling Potential Modernization of Current Lab Regulatory Scheme
National Law Review
HHS-OIG Issues Unfavorable Advisory Opinion on Pay-to-Play Referral Software Platform Arrangement
National Law Review
OIG Raises Anti-Kickback Concerns About Subscription-Based Referral Management Platforms
National Law Review
CMS Seeks Guidance on Medicare Part D PBM Reform under the CAA 2026
National Law Review